Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The new director of the NIH defended herself before the Dingell committee last week but also promised self-restraint. But she has a strong case for reforming the OSI.
The new biology has spawned a new industry — that of ethical enquiries into the new biology. But the ethical problems are often neither new nor problematical. Hard heads and plain speaking are the urgent needs.
Contrary to most accounts, last week's summit meeting in London was not a waste of time, but an occasion when several national leaders made promises they can now be asked to keep.
Protests against the proposed space station Freedom continue, but the US Congress is likely to approve the project. The time has come for counter-arguments of a different kind.
Two large companies, IBM in the United States and ICI in Britain, suddenly look vulnerable. Is the explanation their sheer size or, more probably, their ingrained habits?
The well-substantiated deviousness of Iraq in attempting to conceal its nuclear facilities should remind the rest of us that there needs to be a durable way of regulating engineering exports.
The British government seems reconciled to yet another European meeting when it is in a minority of one, but the whole of Europe needs better preparation for the grand schemes now under way.
Efforts to reach agreement on the use of genetic information will be frustrated while the world – and people's capacity to live with truth – is changing as quickly as at present.